Please assess the completion status of the following clinical trial:

Trial Title: Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years old, both men and women~* Existing implantable cardioverter-defibrillator (ICD)~* Referred for implantation of a continuous flow LVAD~Exclusion Criteria:~* Permanent left ventricular epicardial defibrillator in place~* Congenital heart disease with single ventricle physiology~* Right ventricular assist device (RVAD) in place~* Existing pacing indication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Native Conduction (Type: PLACEBO_COMPARATOR): Devices will be programmed to continuous atrial pacing at an AAI (atrial inhibited pacing) setting with base rate 90 bpm. Patients will not receive ventricular pacing.
- Continuous RV Pacing (Type: EXPERIMENTAL): Devices will be programmed to continuous dual chamber pacing at a DDD (dual chamber dual pacing) setting with base rate ≥ 90 bpm (not to exceed 100 bpm) to achieve a majority (\>80%) of paced right ventricular beats

Based on this trial design, predict the completion outcome and termination type (if applicable).